Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asthma therapy during pregnancy.

Pascal Demoly1, Vincent Piette, Jean-Pierre Daures

  • 1Exploration des Allergies--Maladies Respiratoires--INSERM U454, Hôpital Arnaud de Villeneuve, Institut Universitaire de Recherche Clinique de Montpellier, University Hospital of Montpellier, 34295 Montpellier Cedex 5, France. demoly@montp.inserm.fr

Expert Opinion on Pharmacotherapy
|July 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Xpert® bladder Cancer monitor urine test for non-muscle-invasive bladder cancer surveillance: a prospective clinical trial.

Clinica chimica acta; international journal of clinical chemistry·2026
Same author

Association Between Domestic Mold Detection and Clinical Outcomes in House Dust Mite Allergic Patients.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Allergic rhinitis activity and efficacy of 300 IR house dust mite sublingual immunotherapy tablet in pediatrics.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Management and Immunotherapy for Fungal Allergy: Clinical Practice and Unmet Needs.

Clinical reviews in allergy & immunology·2026
Same author

Performance of the I3A Scoring System for Risk Stratification in a Retrospective Cohort of Children With Ibuprofen-Induced NSAID Hypersensitivity.

The journal of allergy and clinical immunology. In practice·2026
Same author

Patient-Perceived Benefits of Named-Patient Product Sublingual Immunotherapy in Allergic Rhinitis and Asthma: Primary Results From the ERAPP Real-World Cohort Study.

Allergy·2026
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Asthma medications are often necessary during pregnancy. This review examines current literature on managing asthma in pregnant individuals, emphasizing safe medication choices when benefits outweigh risks.

Area of Science:

  • Obstetrics and Gynecology
  • Pulmonology
  • Pharmacology

Background:

  • Asthma affects numerous pregnant women, necessitating medication use.
  • Pregnancy-related physiological changes can alter airway responsiveness.
  • Current understanding of asthma medication safety during pregnancy requires further development.

Purpose of the Study:

  • To review the current literature on asthma management in pregnant individuals.
  • To highlight the importance of risk-benefit assessment for asthma medications during pregnancy.
  • To identify generally safe asthma medication options for use during pregnancy.

Main Methods:

  • Literature review of current scientific publications.
  • Analysis of asthma management guidelines, including Global Initiative for Asthma (GINA).

Related Experiment Videos

  • Focus on risk-benefit evaluation for prescribing asthma drugs in pregnant patients.

    • Main Results:

    • Asthma medication use during pregnancy is common and sometimes essential.
    • Physiological changes in pregnancy can impact asthma control.
    • Guidelines recommend prescribing medications when benefits exceed risks, with usually safe options available.

    Conclusions:

    • Careful consideration and attention are required when prescribing asthma medications to pregnant women.
    • The established benefit of a medication must outweigh its potential risk.
    • Available literature suggests generally safe asthma drug choices exist for pregnant patients.